A comparison of efficacy and safety of Antihypertensive drugs used in combination and adherence to medication in patients of Hypertensio
Not Applicable
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2023/09/057435
- Lead Sponsor
- Dr. Madhumita Dixit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Newly diagnosed patients
2. Patients of either sex
3. Age = 18
4. Patients with confirmed diagnosis of Hypertension based on clinical presentation and JNC 8 criteria
5. Patients with no other comorbidities
Exclusion Criteria
1. Age < 18
2. Patients with other comorbidities
3. Previously diagnosed hypertensive patients
4. Secondary Hypertension
5. Patient not giving consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)Comparative analysis of efficacy of combination of Hydrochlorothiazide + Amlodipine vs Hydrochlorothiazide + Telmisartan vs Hydrochlorothiazide + Ramipril <br/ ><br> <br/ ><br>2)Comparative analysis of safety of combination of (Hydrochlorothiazide + Amlodipine vs Hydrochlorothiazide + Telmisartan vs Hydrochlorothiazide + Ramipril) <br/ ><br> <br/ ><br>3)Comparison of Adherence of patients to combination of Hydrochlorothiazide + Amlodipine vs Hydrochlorothiazide + Telmisartan vs Hydrochlorothiazide + Ramipril <br/ ><br> <br/ ><br>4)Comparative analysis of Pharmacoeconomic considerations of Hydrochlorothiazide + Amlodipine vs Hydrochlorothiazide + Telmisartan vs Hydrochlorothiazide + Ramipril <br/ ><br>Timepoint: 1 month
- Secondary Outcome Measures
Name Time Method Diabetes ,dyslipidemia, ADR monitoringTimepoint: 1 year